Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure?

By sjmartinez • October 18, 2023

John N, Ibrahim B, Ebaid M, Saab S. Outcomes in Patients with Liver Dysfunction Post SARS-CoV-2 Infection: What Should We Measure? Hepat Med. 2023 Oct 12;15:185-193. doi: 10.2147/HMER.S371507. PMID: 37850074; PMCID: PMC10578169.

Tags: cholangiopathy, Cirrhosis, covid-19, Digestive Diseases, Fellow, liver injury, Publications, Thrombosis

Related Posts

Corrigendum to “Subchronic inhalation exposure to ultrafine particulate matter alters the intestinal microbiome in various mouse models” [Environ. Res. 248 (2024) 118242]

Chang C, Gupta R, Sedighian F, Louie A, Gonzalez DM, Le C, Cho JM, Park SK, Castellanos J, Ting TW, Dong TS, Arias-Jayo N, Lagishetty[...]

Effectiveness of transoral endoscopic fundoplication with or without hiatal hernia repair in patients with gerd and chronic cough

Swei E, Almario JA, Dunbar K, Yadlapati R, Parker B, Brewer-Gutierrez O, Janu P, Murray M, Sohagia A, Diehl DL, Khara H, Abu Dayyeh B,[...]

Identification of a PRDM1-regulated T cell network to regulate atherosclerotic plaque inflammation

Jin H, Maas SL, Zou Y, Lu C, Yu B, Huchzermeier R, Nadeau S, Dos Santos J, Gijbels M, Mees BME, Smirnov E, Matic L,[...]